Bosch Health Campus Monthly Research Seminar

26.02.2025      

Prof. Dr. Bettina Weigelin, University of Tübingen
Multiscale microscopic imaging to understand systemic cancer immunotherapy response

01.04.2025      

Dr. Roberto Würth, German Cancer Research Center (DKFZ), Heidelberg
Liquid Biopsy: A Window into Metastatic Cancer Evolution

07.04.2025      

Dr. Angelika Feldmann, German Cancer Research Center (DKFZ), Heidelberg
Is timing everything? Towards understanding the temporality of enhancer-promoter contacts

08.04.2025      

Univ.-Prof. Dr. med. Philipp Jost, Medical University and Comprehensive Cancer Center, Graz
Inflammation, cell death and oncogenic signaling: an (un)happy triad

14.04.2025      

Dr. Florian Wimmers,  University of Tübingen
Systems immunological assessment of human immune responses

21.05.2025      

Dr. Suchira Gallage,  M3 Research Center, University Hospital Tübingen
Lifestyle Interventions in MASH and Liver Cancer

11.06.2025      

Junior Professor Harrisen Scells,  Institute for Applied Medical Informatics, University Tübingen
Knowledge-Enhanced Automatic Search Formulation for Systematic Reviews

23.07.2025      

Prof. Dr. Martin Fromm,  Institute of Experimental and Clinical Pharmacology and Toxicology, Friedrich-Alexander-University Erlangen-Nürnberg
Biomarkers for transporter-mediated drug-drug interactions and medication safety in oncology

28.07.2025      

Prof. Ralf Janknecht,  Cell Biology, University of Oklahoma Health Sciences Center
Oncogenic Enigmas: The Epigenetic Regulator JMJD5 and the Nucleotide Hydrolase DNPH1

11.08.2025      

Dr. Ashish Goyal,  Assistant Professor at Cancer related Advanced Research and Education (CARE), India
Epigenetic Therapies Induced Antigens - A new class of immunotherapy targets

01.09.2025      

Dr. Marit Vermunt,  Junior Research Group Leader, Goethe University Frankfurt
CTCF, DNA methylation and antisense transcription in leukemia

22.09.2025      

Dr. Daniel Dauch,  Research Group Leader, Targeted therapies and therapy resistance in gastrointestinal tumors, University Hospital Tübingen
Targeting essential mechanisms in gastrointestinal cancer to overcome therapy resistance

24.09.2025      

PD Dr. med. Michael Jeitler, Institute of Social Medicine, Epidemiology and Health Economics, Charité - University Medicine Berlin
Greenspaces, Nature-Based Interventions and human health

06.10.2025      

Dr. Sandra Schick,  Group Leader Institute of Molecular Biology (IMB), Mainz
BAF chromatin remodellers in colon homeostasis and cancer

Dr.med.Dr.med.univ. Jan Valentini, Complementary and integrative medicine, University Hospital Tuebingen
Decoding Acupuncture: Exploring the Neuro-Psycho-Endocrine-Immunological-Axis-Current Evidence and Insights

Prof. Dr. Robert Lukowski,  Institute of Pharmacy, University of Tübingen
Breast cancer-promoting effects of (mitochondrial) BKCaK+ channels: A journey through metabolic reprogramming and hormone therapy

Prof. Nicoletta Bobola, Faculty of Biology, Medicine and Health, University of Manchester
Ubiquitous transcriptional regulators: master keys to unlock lineage differentiation?

Dr.med. Jan Vagedes M.A. ,  Chief Physician, Pediatrics, Filder Clinic; ARCIM Institute
Heart Rate Variability as a tool to measure stress levels of our autonomic nerve system

Apl . Prof. Dr. med. Lusine Danielyan,  Deputy Medical Director of the Clinical Department pharmacology, University Hospital Tuebingen
Advanced Cell Therapies and Delivery Techniques for Brain Disorders

Prof. Dr. rer. med. Alexander Kleger, Institute of Molecular Oncology andStem Cell Biology (IMOS) –University Clinic Ulm
Pancreatic disorders illuminated by pancreatic organoids

Dr. Jeremy Y. Ng, Centre for Journalology, Ottawa Methods Centre, Ottawa Hospital Research Institute, Ottawa, Canada
Using Open Science and Meta-Research Findings to Improve Quality and Address Challenges Medical Research

Prof. Gert Fricker,  Ruprecht-Karls-University Heidelberg, Institute of Pharmacyand Molecular Biotechnology, Dept. Pharmaceutical Technology and Biopharmacy
The blood-brain-barrier: A gateway to the CNS?

Prof. Dr. Jörn Lausen, University of Stuttgart
Gene expression control in differentiation and disease

Prof. Dr. Gustav Dobos , Center for Naturopathy and Integrative Medicine at the University Hospital Essen
Planetary Health Diet: Healthy eating for people and planet. What is the evidence?

Prof. Dr. André F. Martins , Full Professor in Advanced Preclinical Metabolic Imaging and Cell Engineering, University Hospital Tübingen
Harnessing metabolic imaging to monitor cancer aggressiveness non-invasively in vivo

PD Dr. Daniel Lipka , National Center for Tumor Diseases (NCT) Heidelberg & German Cancer Research Center (DKFZ)
RAS Pathway Mutations Drive Onco Fetal Reprogramming in Juvenile Myelomonocytic Leukemia

Prof. Dr. Verena Labi , Institute of Developmental Immunology, Medical University of Innsbruck
Roles of epigenetic TET enzymes in hematologic cancers and immunity

Prof. Dr. Sonja Loges, Medical Faculty Mannheim, Heidelberg University
Precision Oncology - from bench to bedside

Dr. Jeremy Y. Ng , Centre for Journalology , Ottawa Methods Centre, Ottawa Hospital Research Institute, Ottawa, Canada
Basic Principles in Scholarly Publishing and Open Science Practices: A Primer

Prof. Dr. Thomas Ostermann, Chair of Research Methodology and Statistics in Psychology, Department of Psychology and Psychotherapy, Faculty of Health, Witten/Herdecke University
Regression to the mean – A statistical phenomenon, its occurrence and detection

Prof. Dr. Lisa Maier , Interfaculty Institute of Microbiology and Infection Medicine, University of Tübingen
The consequences of drugging the gut microbiome –from the individual microbe to the host